Design, Optimization, and Multisite Evaluation of a Targeted Next-Generation Sequencing Assay System for Chimeric RNAs from Gene Fusions and Exon-Skipping Events in Non–Small Cell Lung Cancer

Lung cancer accounts for approximately 14% of all newly diagnosed cancers and is the leading cause of cancer-related deaths. Chimeric RNA resulting from gene fusions (RNA fusions) and other RNA splicing errors are driver events and clinically addressable targets for non–small cell lung cancer (NSCLC...

Descripción completa

Detalles Bibliográficos
Autores principales: Blidner, Richard A., Haynes, Brian C., Hyter, Stephen, Schmitt, Sarah, Pessetto, Ziyan Y., Godwin, Andrew K., Su, Dan, Hurban, Patrick, van Kempen, Léon C., Aguirre, Maria L., Gokul, Shobha, Cardwell, Robyn D., Latham, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Investigative Pathology 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057224/
https://www.ncbi.nlm.nih.gov/pubmed/30529127
http://dx.doi.org/10.1016/j.jmoldx.2018.10.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057224/
https://www.ncbi.nlm.nih.gov/pubmed/30529127
http://dx.doi.org/10.1016/j.jmoldx.2018.10.003

Ejemplares similares